Does AMLODIPINE Cause Product physical consistency issue? 8 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Product physical consistency issue have been filed in association with AMLODIPINE (Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide). This represents 0.0% of all adverse event reports for AMLODIPINE.
8
Reports of Product physical consistency issue with AMLODIPINE
0.0%
of all AMLODIPINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product physical consistency issue From AMLODIPINE?
Of the 8 reports.
Is Product physical consistency issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMLODIPINE. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does AMLODIPINE Cause?
Hypotension (6,504)
Toxicity to various agents (5,554)
Completed suicide (5,267)
Drug ineffective (4,091)
Dyspnoea (3,907)
Dizziness (3,536)
Intentional overdose (3,427)
Fall (3,215)
Fatigue (3,141)
Headache (2,907)
What Other Drugs Cause Product physical consistency issue?
LEUPROLIDE (926)
CLASCOTERONE (317)
BUPRENORPHINE (242)
MINOXIDIL (171)
CHOLESTYRAMINE (141)
NAPROXEN (117)
TESTOSTERONE (113)
RUXOLITINIB (103)
DEVICE (85)
CLOBETASOL (76)
Which AMLODIPINE Alternatives Have Lower Product physical consistency issue Risk?
AMLODIPINE vs AMLODIPINE BESILATE
AMLODIPINE vs AMLODIPINE\ATORVASTATIN
AMLODIPINE vs AMLODIPINE\BENAZEPRIL
AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN
AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL